AERIE PHARMACEUTICALS INC's ticker is AERI and the CUSIP is 00771V108. A total of 159 filers reported holding AERIE PHARMACEUTICALS INC in Q1 2020. The put-call ratio across all filers is 9.03 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $287,000 | -34.3% | 25,481 | -6.4% | 0.00% | 0.0% |
| Q2 2021 | $437,000 | -0.9% | 27,222 | +9.9% | 0.00% | 0.0% |
| Q1 2021 | $441,000 | +93.4% | 24,781 | +45.9% | 0.00% | 0.0% |
| Q4 2020 | $228,000 | +5.1% | 16,987 | +89.1% | 0.00% | 0.0% |
| Q4 2019 | $217,000 | -15.2% | 8,984 | +83.0% | 0.00% | -50.0% |
| Q2 2017 | $256,000 | -79.4% | 4,909 | -82.1% | 0.00% | -83.3% |
| Q1 2017 | $1,243,000 | +29.5% | 27,426 | +7.5% | 0.01% | +20.0% |
| Q4 2016 | $960,000 | +20.9% | 25,519 | +20.8% | 0.01% | +11.1% |
| Q3 2016 | $794,000 | – | 21,124 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Foresite Capital Management II, LLC | 805,217 | $14,212,000 | 4.99% |
| DAFNA Capital Management LLC | 156,842 | $2,768,000 | 2.34% |
| NORTHPOINTE CAPITAL LLC | 1,034,400 | $18,257,000 | 2.15% |
| HARVEY CAPITAL MANAGEMENT INC | 223,200 | $3,856,000 | 1.30% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 2,211,644 | $39,036,000 | 1.30% |
| Boulegeris Investments, Inc. | 88,660 | $1,565,000 | 1.12% |
| Partner Investment Management, L.P. | 43,623 | $770,000 | 1.08% |
| SUMMIT PARTNERS PUBLIC ASSET MANAGEMENT, LLC | 150,000 | $2,648,000 | 0.92% |
| PFM Health Sciences, LP | 1,851,564 | $32,680,000 | 0.83% |
| Benchmark Capital Advisors | 55,400 | $978,000 | 0.69% |